We develop AI-driven solutions for precision medicine that turn complex biomedical and pathology data into actionable insights to accelerate drug development and improve patient outcomes. Our mission is to deliver reproducible, clinically-relevant analytics that enable better target identification, biomarker discovery, and diagnostic decision support.

We provide a portfolio of products and custom services for biomedical research and regulated clinical applications, including foundation models for pathology, and the Atlas H&E-TME tumor microenvironment profiling application.

Key services include:

We collaborate with academic and industry partners to co-develop models and validate performance across large, multimodal cohorts.

Aignostics is a Charité Berlin spin-off with teams in Berlin and New York, combining data scientists, ML engineers, pathologists and biologists. We have proprietary access to multimodal data covering over 30 million patients at leading hospitals and labs. Our platforms are ISO 13485 and ISO 27001 certified and GCP-ready for clinical trial use.